CClinicalTrials.gg
CompletedNCT02637830Updated Dec 24, 2015

In Situ Remineralisation Response of Different Artificial Caries-like Enamel Lesions to Home-care and Professional Fluoride Treatments

An interventional study of Application of fluoride varnish (22600 ppm F, Duraphat) at the begining of the study and Application of fluoride toothpaste (1500 ppm F, Crest) twice a day for 3 days of the study in Dental Caries, sponsored by University of Sao Paulo. Completed. Open to participants aged 18 Years to 30 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2015-12-24.

Sponsored by University of Sao Paulo · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
12
Allocation
Randomized
Ages
18 Years to 30 Years
Sex
All
01

Study summary

This study mainly compared the response of the artificial carious enamel lesions to remineralisation in situ. The tested in vitro demineralising protocols were: MC gel, PA gel, MHDP and Buffer solutions.

The lesions were then remineralised in an in situ model, with crossover and double blind design. Fifteen volunteers wore intra-oral appliances containing 2 bovine enamel samples of each demineralising protocol during 3 experimental phases (3 days each). The experimental phases/treatments were: Control (Placebo dentifrice, saliva effect only), Home-care (fluoride dentifrice, 1,100 ppm F, NaF), and Professional/Home-care (varnish- 22,600 ppm F and dentifrice- 1,100 ppm F, NaF).

During the 3-day phase, the appliance was only removed during the main meals (four times a day, maximum 1 h duration each, interval between meals 2-3 h). Immediately after the meals, before replacing the appliance in the mouth, the subjects were advised to perform oral hygiene using a soft end-rounded toothbrush (Colgate® 360º Sensitive Pro-Relief TM) and dentifrice (non-fluoridated from IceFresh, Bauru, SP, Brazil or fluoridated dentifrice from Crest Procter \& Gamble, Cincinnati, OH, USA) according to the phase and dental floss (Sanifill, São Paulo, Brazil).

The remineralising treatment with dentifrices was done ex vivo, 1 min twice a day (after the first and last oral hygiene of the day) using slurry of the dentifrice (1:3 water, 1 drop of solution/specimen). Thereafter, the appliance was replaced in the mouth and the subjects were advised to rinse with 10 ml of water for 5 s and to expectorate. In respect to Professional/Home-care phase, the varnish (Duraphat, Colgate, SP, Brazil) was applied before the in situ study for 6h and then removed.

The enamel remineralization was quantified using transverse microradiography (% mineral recovery and lesion depth, TMR), surface and cross-sectional hardness. The data were submitted to statistical analysis (p\<0.05).

02

Conditions studied

  • Dental Caries

Browse trials for

03

In context

Dental Caries

1,109 studies on the registry are indexed under Dental Caries; 197 are open to participants now.

This study's enrollment of 12 is below the median of 60 across 916 interventional studies indexed under Dental Caries.

Browse Dental Caries studies →

Lead sponsor

University of Sao Paulo is the lead sponsor of 1,005 studies on the registry; 90 are open to participants now.

Of its 7 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 30 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • a stimulated physiological salivary flow rate of >1 ml.min-1
  • a non-stimulated physiological salivary flow rate of >0.25 ml.min-1
  • good oral health (i.e. no cavities or significant gingivitis/periodontitis)

Exclusion criteria

Exclusion Criteria:

  • systemic illness
  • pregnancy or breastfeeding
  • use of fixed or removable orthodontic appliances
  • use of fluoride mouthrinse or professional fluoride application in the last 2 months.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Double (Participant, Investigator)
Enrollment
12 participants (actual)

Study arms

  • Experimental
    Fluoride varnish and fluoride toothpaste

    Application of fluoride varnish (Duraphat) at the begining of the study. Application of fluoride toothpaste (Crest) twice a day for 3 days.

    Other: Application of fluoride varnish (22600 ppm F, Duraphat) at the begining of the study · Other: Application of fluoride toothpaste (1500 ppm F, Crest) twice a day for 3 days of the study

  • Placebo comparator
    placebo toothpaste

    Application of placebo toothpaste twice a day for 3 days

    Other: Application of placebo toothpaste (0 ppm F, Ice Fresh) twice a day for 3 days of the study

  • Active comparator
    Fluoride toothpaste

    Application of fluoride toothpaste (Crest) twice a day for 3 days

    Other: Application of fluoride toothpaste (1500 ppm F, Crest) twice a day for 3 days of the study

Interventions

  • OtherApplication of fluoride varnish (22600 ppm F, Duraphat) at the begining of the study
  • OtherApplication of fluoride toothpaste (1500 ppm F, Crest) twice a day for 3 days of the study
  • OtherApplication of placebo toothpaste (0 ppm F, Ice Fresh) twice a day for 3 days of the study
06

What researchers measure

Primary outcomes

  1. The increase of mineral content (% mineral volume) using transverse microradiography

    Time frame: 3 days

  2. The increase of hardness (KHN or KgF/mm2) artificial caries lesions using surface and cross-sectional hardness

    Time frame: 3 days

  3. Decrease of lesion depth (microns) of artificial caries lesions using transverse microradiography

    Time frame: 3 days

07

Study locations

No study locations are listed for this record.

08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 24, 2015, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02637830
Lead sponsor
University of Sao Paulo
Responsible party
Ana Carolina Magalhães (Prof. Dr., University of Sao Paulo) — Principal investigator
First posted
Dec 22, 2015
Start date
Jan 2012
Primary completion
Jun 2012
Completion
Dec 2012
Last update
Dec 24, 2015
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2015. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion